LD-2 disclosure · 3rd Quarter - Report
ACURX PHARMACEUTICALS, INC.
Client
- Name
- ACURX PHARMACEUTICALS, INC.
- Description
- biopharmaceutical company
- Location
- New York · United States of America
Registrant
- Description
- government relations
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
H.R.4026/S.2572, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.5304/S.2587, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
LobbyistsLETITIA WHITE · CARL KIME · ERYNN D HOOK
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
H.R.3838/S.2296, National Defense Authorization Act, 2026, Title II, all provisions related to biodefense preparedness.
LobbyistsLETITIA WHITE · CARL KIME · ERYNN D HOOK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Navy, Dept of · Defense Threat Reduction Agency (DTRA)